Hutch News
Results per Page:
How does leukemia escape from immunotherapy?
Single-cell sequencing tech enables deep dive into mysterious results, sets stage for future improvements
Immunotherapy strategy for ovarian cancer aims to rewire a ‘kill switch’ to ramp-up signal
T cells bearing a new engineered protein boost immunotherapy’s effectiveness in laboratory models of AML, ovarian, pancreatic cancers
Fred Hutch scientists to feature next-generation T-cell therapies, big data, precision medicine and more at AACR
The American Association for Cancer Research will hold its 111th annual meeting April 14-18 in Chicago
Learning more from T-cell therapy trials
Fred Hutch Immunotherapy Integrated Research Center awards grants to Drs. Brian Till, Cameron Turtle
Should prostate cancer screening be different for black men?
New study confirms prostate cancer is more common and more deadly in African-Americans
Immunotherapy for ovarian cancer shows promise in mouse model, but hurdles remain
‘Tumor microenvironment’ poses unique challenges for T-cell therapy in solid tumors
Finding ways to deliver on the promise of precision oncology
‘Functional genomics’ method aims to marry three powerful techniques to speed personalized cancer treatments to patients
Capturing information from thousands of cells at once
New technology allows scientists to peek inside nearly 70,000 cells in single experiment
Immunotherapy shows promise in preventing leukemia relapse
Group of 12 high-risk patients who received engineered T cells after bone marrow transplant still in remission after more than two years
Progress in ‘precision prevention’ for colorectal cancer
New risk prediction model — not yet ready for clinical use — incorporates genetic, lifestyle and environmental risk factors